发明名称 Behandling med anti-ErbB2-antistoffer
摘要 The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
申请公布号 NO20002957(A) 申请公布日期 2000.08.11
申请号 NO20000002957 申请日期 2000.06.09
申请人 GENENTECH INC 发明人 SHAK, STEVEN;PATON, VIRGINIA E
分类号 C12N15/09;A61K31/335;A61K38/00;A61K39/395;A61K45/06;A61P35/00;A61P43/00;C07K16/32;C12P21/08;(IPC1-7):A61K39/395;A61P35/04 主分类号 C12N15/09
代理机构 代理人
主权项
地址